Project Grant R03DE035681
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded a Project Grant of $1,608,956 to Lawrence Berkeley National Laboratory, effective July 1, 2025 through March 31, 2030, under the Oral Diseases and Disorders Research program (CFDA 93.121). This award funds the development of a single-cell multimodal atlas of human craniofacial development to address the genetic basis of midface developmental anomalies, including cleft lip and palate. The...
- Federal Grant Award Summary The University of Delaware received a $315,289 Project Grant (R03) from the National Institute of Dental and Craniofacial Research under the Oral Diseases and Disorders Research program (CFDA 93.121), awarded on July 15, 2025, with completion targeted for July 14, 2027. This research project investigates the role of the SIX1 transcription factor in neural crest cell fate decisions within the mandibular arch at single-cell resolution. The grant supports basic...
- Federal Grant Award Summary The National Institute of Child Health and Human Development (NICHD), under its Child Health and Human Development Extramural Research program (CFDA 93.865), awarded a $787,340 project grant to The University of Kentucky Research Foundation on May 1, 2025, with a completion date of January 31, 2030. This research initiative, titled "Functional Characterization of Genetic Variants in Rare Disease Associated with SHOC2 Scaffold," will deliver comprehensive...
- Federal Grant Award Summary Baylor College of Medicine received a $100,676 Project Grant from the National Institute of Dental and Craniofacial Research under the Oral Diseases and Disorders Research program (CFDA 93.121), awarded on December 13, 2025, with a completion date of November 30, 2027. The grant supports research investigating the molecular etiology of Keratinocyte Differentiation Factor 1 (KDF1) in disease phenotypes of the ectoderm. The research aims to establish...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research awarded a $521,362 Project Grant to The Johns Hopkins University beginning August 12, 2025, and concluding August 11, 2027, under the Oral Diseases and Disorders Research program (CFDA 93.121). The award supports fundamental research aimed at decoding neuroimmune interactions to enhance craniofacial bone healing. The research will employ quantitative light-sheet microscopy (QLSM) and single-cell RNA sequencing...
- Federal Project Grant Award Summary The Jackson Laboratory received a $795,730 Project Grant from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), effective March 1, 2026 through February 28, 2031. This award supports a systems genomics research initiative focused on elucidating the genetic, transcriptional, and histological mechanisms underlying palate morphogenesis using genetically diverse mouse models....
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded The University of Iowa a Project Grant valued at $503,648 under the Oral Diseases and Disorders Research program (CFDA 93.121), effective June 13, 2025, with completion targeted for March 31, 2030. This research grant supports a comprehensive investigation into the transcriptional mechanisms governing mandibular patterning during oral and craniofacial development. The project examines how...
- This Project Grant award from the National Institute of Dental and Craniofacial Research (NIDCR), under the Oral Diseases and Disorders Research program (CFDA 93.121), will support research to establish a novel zebrafish model of syndromic craniosynostosis. The $313,000 award to Emory University will enable comprehensive phenotypic, mechanistic, and genetic analyses of the craniosynostosis mutant zebrafish to better understand the underlying pathological mechanisms. The research aims to identify...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research awarded the University of Pittsburgh a $1.18 million Project Grant under the Oral Diseases and Disorders Research program (CFDA 93.121) effective May 1, 2025, with completion scheduled for February 28, 2030. This award supports research leveraging whole genome sequencing (WGS) and functional genomic characterization to advance gene discovery for nonsyndromic cleft lip and palate (NSCLP), a common birth...
- Federal Grant Award Summary The National Institute of Dental and Craniofacial Research (NIDCR) awarded $451,000 to The Regents of the University of California, San Francisco under the Oral Diseases and Disorders Research program (CFDA 93.121) on August 8, 2025, for a two-year project concluding August 7, 2027. The award funds the development and characterization of metastatic MYB-NFIB fusion adenoid cystic carcinoma (ACC) cell line models to advance understanding of this rare but aggressive...
The National Institute of Dental and Craniofacial Research (NIDCR) awarded The University of Kentucky Research Foundation a $154,000 Project Grant effective March 1, 2026, through February 28, 2027, under the Oral Diseases and Disorders Research program (CFDA 93.121). The grant funds research to elucidate the etiology of Schneckenbecken Dysplasia (SBD), a rare congenital skeletal disease caused by mutations in the SLC35D1 gene. The research employs Xenopus tropicalis (African clawed frog) vertebrate models with CRISPR-generated patient-specific variants to investigate how loss of SLC35D1 function impairs chondrogenesis and craniofacial cartilage development. The deliverables include mechanistic insights into the developmental timing of neural crest disruption in SBD, characterization of how patient-specific variants affect facial phenotypes, and determination of how SLC35D1 loss alters extracellular matrix composition and mechanical signaling during chondrogenesis. The research will establish tractable disease models for SBD with the specific goal of supporting the development of therapeutic approaches for this rare disease. Results will advance understanding of extracellular matrix function in craniofacial development and provide a foundation for future therapeutic interventions.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $154.0k | 2/17/26 |